SG11201406182PA - Fused azole derivative - Google Patents
Fused azole derivativeInfo
- Publication number
- SG11201406182PA SG11201406182PA SG11201406182PA SG11201406182PA SG11201406182PA SG 11201406182P A SG11201406182P A SG 11201406182PA SG 11201406182P A SG11201406182P A SG 11201406182PA SG 11201406182P A SG11201406182P A SG 11201406182PA SG 11201406182P A SG11201406182P A SG 11201406182PA
- Authority
- SG
- Singapore
- Prior art keywords
- azole derivative
- fused azole
- fused
- derivative
- azole
- Prior art date
Links
- 150000007980 azole derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012079473 | 2012-03-30 | ||
PCT/JP2013/059457 WO2013147117A1 (en) | 2012-03-30 | 2013-03-29 | Fused azole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201406182PA true SG11201406182PA (en) | 2014-10-30 |
Family
ID=49260359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201406182PA SG11201406182PA (en) | 2012-03-30 | 2013-03-29 | Fused azole derivative |
Country Status (17)
Country | Link |
---|---|
US (1) | US20150045551A1 (en) |
EP (1) | EP2832722A4 (en) |
JP (1) | JPWO2013147117A1 (en) |
KR (1) | KR20140142244A (en) |
CN (1) | CN104185625A (en) |
AU (1) | AU2013241076A1 (en) |
CA (1) | CA2868388A1 (en) |
HK (1) | HK1200829A1 (en) |
IL (1) | IL234704A0 (en) |
MX (1) | MX2014011756A (en) |
NZ (1) | NZ629944A (en) |
PH (1) | PH12014502178A1 (en) |
RU (1) | RU2014143794A (en) |
SG (1) | SG11201406182PA (en) |
TW (1) | TW201400455A (en) |
WO (1) | WO2013147117A1 (en) |
ZA (1) | ZA201407177B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201205243D0 (en) | 2012-03-26 | 2012-05-09 | Kraft Foods R & D Inc | Packaging and method of opening |
SG11201406182PA (en) * | 2012-03-30 | 2014-10-30 | Taisho Pharmaceutical Co Ltd | Fused azole derivative |
GB2511560B (en) | 2013-03-07 | 2018-11-14 | Mondelez Uk R&D Ltd | Improved Packaging and Method of Forming Packaging |
GB2511559B (en) | 2013-03-07 | 2018-11-14 | Mondelez Uk R&D Ltd | Improved Packaging and Method of Forming Packaging |
KR20170074811A (en) | 2015-12-22 | 2017-06-30 | 삼성전자주식회사 | Condensed cyclic compound, composition and organic light emitting device including the same and method for preparing the organic light emitting device |
CN107082763A (en) * | 2016-02-15 | 2017-08-22 | 中山大学 | A kind of method for synthesizing indazole ketone compounds |
CN111285819A (en) * | 2018-12-07 | 2020-06-16 | 江苏恩华药业股份有限公司 | Benzoxazole compound and application thereof |
WO2020135771A1 (en) * | 2018-12-29 | 2020-07-02 | 武汉朗来科技发展有限公司 | Heterocyclic compound intermediate, preparation method therefor and application thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2804114B1 (en) | 2000-01-25 | 2002-03-08 | Sanofi Synthelabo | NOVEL 1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
JP4618127B2 (en) | 2003-08-28 | 2011-01-26 | 大正製薬株式会社 | 1,3-dihydro-2H-indol-2-one derivatives |
US20050070718A1 (en) | 2003-09-30 | 2005-03-31 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
CA2578075A1 (en) | 2004-08-26 | 2006-03-02 | Pfizer Inc. | Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
TW200643015A (en) | 2005-03-11 | 2006-12-16 | Akzo Nobel Nv | 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives |
CN101258134B (en) * | 2005-03-11 | 2011-10-12 | 欧加农股份有限公司 | 2-(4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists |
US9597314B2 (en) | 2005-03-22 | 2017-03-21 | Azevan Pharmaceuticals, Inc. | Beta-lactamylalkanoic acids for treating premenstrual disorders |
US8350043B2 (en) | 2005-06-07 | 2013-01-08 | Pharmacopeia, Inc. | Azinone and diazinone V3 inhibitors for depression and stress disorders |
WO2007109098A2 (en) | 2006-03-16 | 2007-09-27 | Azevan Pharmaceuticals, Inc. | HYDROXY AND KETO-SUBSTITUTED β-LACTAMYL ALKANEDIOIC ACIDS |
JP5437070B2 (en) | 2006-08-26 | 2014-03-12 | アボット ゲーエムベーハー ウント カンパニー カーゲー | Substituted benzimidazolone derivatives, drugs containing the same and uses thereof |
EP2066640B1 (en) * | 2006-09-11 | 2011-09-07 | N.V. Organon | 2-(1-oxo-1h-isoquinolin-2-yl) acetamide derivatives |
ATE523500T1 (en) * | 2006-09-11 | 2011-09-15 | Organon Nv | QUINAZOLINONE AND ISOQUINOLINONE ACETAMIDE DERIVATIVES |
WO2008133867A1 (en) * | 2007-04-26 | 2008-11-06 | Merck & Co., Inc. | 2-substituted indole derivatives as calcium channel blockers |
JP2010229035A (en) * | 2007-08-01 | 2010-10-14 | Taisho Pharmaceutical Co Ltd | Pyridopyrimidin-4-one derivative |
WO2009130231A1 (en) * | 2008-04-24 | 2009-10-29 | Glaxo Group Limited | Pyrrolo [1, 2-a] pyrazine derivatives as vasopressin vib receptor antagonists |
WO2009130232A1 (en) | 2008-04-24 | 2009-10-29 | Glaxo Group Limited | Pyrazolo [1, 5 -a] pyrazine derivatives as antagonists of v1b receptors |
JP2013075830A (en) * | 2010-02-03 | 2013-04-25 | Taisho Pharmaceutical Co Ltd | Quinoline derivative |
SG11201406182PA (en) * | 2012-03-30 | 2014-10-30 | Taisho Pharmaceutical Co Ltd | Fused azole derivative |
-
2013
- 2013-03-29 SG SG11201406182PA patent/SG11201406182PA/en unknown
- 2013-03-29 NZ NZ629944A patent/NZ629944A/en not_active IP Right Cessation
- 2013-03-29 WO PCT/JP2013/059457 patent/WO2013147117A1/en active Application Filing
- 2013-03-29 MX MX2014011756A patent/MX2014011756A/en unknown
- 2013-03-29 CN CN201380018334.5A patent/CN104185625A/en active Pending
- 2013-03-29 US US14/387,747 patent/US20150045551A1/en not_active Abandoned
- 2013-03-29 KR KR1020147025923A patent/KR20140142244A/en not_active Application Discontinuation
- 2013-03-29 RU RU2014143794A patent/RU2014143794A/en not_active Application Discontinuation
- 2013-03-29 JP JP2014508075A patent/JPWO2013147117A1/en not_active Withdrawn
- 2013-03-29 TW TW102111564A patent/TW201400455A/en unknown
- 2013-03-29 CA CA2868388A patent/CA2868388A1/en not_active Abandoned
- 2013-03-29 AU AU2013241076A patent/AU2013241076A1/en not_active Abandoned
- 2013-03-29 EP EP13767453.7A patent/EP2832722A4/en not_active Withdrawn
-
2014
- 2014-09-17 IL IL234704A patent/IL234704A0/en unknown
- 2014-09-29 PH PH12014502178A patent/PH12014502178A1/en unknown
- 2014-10-03 ZA ZA2014/07177A patent/ZA201407177B/en unknown
-
2015
- 2015-02-09 HK HK15101399.8A patent/HK1200829A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2832722A1 (en) | 2015-02-04 |
ZA201407177B (en) | 2016-03-30 |
HK1200829A1 (en) | 2015-08-14 |
PH12014502178A1 (en) | 2014-12-10 |
AU2013241076A1 (en) | 2014-10-09 |
US20150045551A1 (en) | 2015-02-12 |
EP2832722A4 (en) | 2015-08-12 |
RU2014143794A (en) | 2016-05-27 |
NZ629944A (en) | 2016-02-26 |
IL234704A0 (en) | 2014-11-30 |
WO2013147117A1 (en) | 2013-10-03 |
JPWO2013147117A1 (en) | 2015-12-14 |
CN104185625A (en) | 2014-12-03 |
CA2868388A1 (en) | 2013-10-03 |
TW201400455A (en) | 2014-01-01 |
KR20140142244A (en) | 2014-12-11 |
MX2014011756A (en) | 2014-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200040I1 (en) | Benzimidazole-proline derivatives | |
EP2862853A4 (en) | Fused heterocyclic compound | |
EP2865671A4 (en) | Fused heterocyclic compound | |
EP2857396A4 (en) | Fused heterocyclic compound | |
EP2857397A4 (en) | Fused heterocyclic compound | |
HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
HK1207375A1 (en) | Piperidinylpyrazolopyridine derivative | |
EP2865672A4 (en) | Fused heterocyclic compound | |
IL236295A (en) | Indanesulfamide derivative | |
HK1200829A1 (en) | Fused azole derivative | |
HK1209115A1 (en) | Imidazole derivative | |
AP2015008347A0 (en) | Oxazolidin-2-one-pyrimidine derivatives | |
HK1200824A1 (en) | Substituted phenylazole derivative | |
PT2873660T (en) | Indolecarboxamide derivative | |
EP2842958A4 (en) | Naphthobisthiadiazole derivative | |
HK1204621A1 (en) | 4-alkanoylamino-3-pyrazolone derivative 4--3- | |
GB201219296D0 (en) | Pyrazole derivatives | |
GB201219289D0 (en) | Pyrazole derivatives | |
GB201218245D0 (en) | Pyrazole derivatives |